Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share.

Healthcare tech company Omnicell (NASDAQ:OMCL) in Q4 CY2025, with sales up 2.3% year on year to $314 million. The company ...

Omnicell (OMCL) stock is upgraded to Buy from Neutral at Bank of America citing a buying opportunity ahead of the company's ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday before market hours. Here’s what investors should know.

In the preceding three months, 7 analysts have released ratings for Omnicell (NASDAQ:OMCL), presenting a wide array of perspectives from bullish to bearish. The table below offers a condensed view of ...

Investing.com -- Omnicell shares have upside as a new product cycle drives revenue revisions, Bank of America said, upgrading the hospital automation company to Buy from Neutral.

On a per-share basis, the Fort Worth, Texas-based company said it had a loss of 5 cents. Earnings, adjusted for one-time gains and costs, came to 40 cents per share. The results fell short of Wall ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability. Revenue for Omnicell in its third ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Omnicell, Inc. (NASDAQ:OMCL) ranks among the list of stocks with improving ...